(1) Aim of the study: In spite of extensive research, up to 20% of interstitial lung diseases (ILD) patients cannot be safely classified. We analyzed clinical features, progression factors, and outcomes of unclassifiable ILD (uILD). (2) Methods: A total of 140 uILD subjects from the University of Giessen and Marburg Lung Center (UGMLC) were recruited between 11/2009 and 01/2019 into the European Registry for idiopathic pulmonary fibrosis (eurIPFreg) and followed until 01/2020. The diagnosis of uILD was applied only when a conclusive diagnosis could not be reached with certainty. (3) Results: In 46.4% of the patients, the uILD diagnosis was due to conflicting clinical, radiological, and pathological data. By applying the diagnostic criteria of usual interstitial pneumonia (UIP) based on computed tomography (CT), published by the Fleischner Society, 22.2% of the patients displayed a typical UIP pattern. We also showed that forced vital capacity (FVC) at baseline (p = 0.008), annual FVC decline >/=10% (p < 0.0001), smoking (p = 0.033), and a diffusing capacity of the lung for carbon monoxide (DLco)
Krauss, E.
El-Guelai, M.
Pons-Kuehnemann, J.
Dartsch, R. C.
Tello, S.
Korfei, M.
Mahavadi, P.
Breithecker, A.
Fink, L.
Stoehr, M.
Majeed, R. W.
Seeger, W.
Crestani, B.
Guenther, A.
Keywords
- European Registry for idiopathic pulmonary fibrosis (eurIPFreg)
- Health-related quality of life (HRQoL)
- idiopathic pulmonary fibrosis (IPF)
- interstitial lung diseases (ILD)
- unclassifiable interstitial lung disease (uILD)
